Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06622941 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to ONO-4538 in Patients With Rhabdoid Tumor

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 5 → 14 locationsv8
  2. Changed Sponsor changed: Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd.
  3. Study sites: 4 to 5v7
  4. Study sites: 3 to 4v6
  5. Site details revised at 1 of 3 sitesv5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 2 to 3v4
  2. Start date changed from estimate of Nov 30, 2024 to Nov 25, 2024v3
  3. Trial status: Not Yet Recruiting to Recruiting Start date: Sep 30, 2024 to Nov 30, 2024 · Secondary endpoints revised (9) · Site details revised at 2 of 2 sites · 1 morev2 Show 4 more changesShow less
    • Start date: Sep 30, 2024 to Nov 30, 2024
    • Secondary endpoints revised (9)
    • Site details revised at 2 of 2 sites
    • Study title shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Trial Details
NCT Number NCT06622941
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Rhabdoid Tumor
Enrollment 23 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov